Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

被引:108
|
作者
Scalone, Luciana [1 ,2 ,3 ]
Ciampichini, Roberta [2 ]
Fagiuoli, Stefano [4 ]
Gardini, Ivan [5 ]
Fusco, Francesco [2 ]
Gaeta, Laura [4 ]
Del Prete, Anna [4 ]
Cesana, Giancarlo [1 ]
Mantovani, Lorenzo G. [2 ,6 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth, CESP, Milan, Italy
[2] CHARTA Fdn, Milan, Italy
[3] Fdn Charta, I-20122 Milan, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Patients Org EpaC ONLUS, Milan, Italy
[6] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy
关键词
Health-related quality of life (HRQoL); Chronic hepatic diseases; EQ-5D-3L; EQ-5D-5L; Psychometric performance; QUALITY-OF-LIFE; LIVER-DISEASE; SPANISH VERSION; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CANDIDATES; UTILITIES; VALIDITY;
D O I
10.1007/s11136-012-0318-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs). We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system. A total of 1,088 valid patients were recruited: 62 % male, 19-89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57-65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved. In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
引用
收藏
页码:1707 / 1716
页数:10
相关论文
共 50 条
  • [31] Utilities of the EQ-5D Transferable or Not?
    Knies, Saskia
    Evers, Silvia M. A. A.
    Candel, Math J. J. M.
    Severens, Johan L.
    Ament, Andre J. H. A.
    PHARMACOECONOMICS, 2009, 27 (09) : 767 - 779
  • [32] A LINGUISTIC EQ-5D PROPOSAL
    De Andres, R.
    Gomez-Costilla, P.
    COMPUTATIONAL INTELLIGENCE: FOUNDATIONS AND APPLICATIONS: PROCEEDINGS OF THE 9TH INTERNATIONAL FLINS CONFERENCE, 2010, 4 : 1036 - +
  • [33] The valuation of the EQ-5D in Portugal
    Lara N. Ferreira
    Pedro L. Ferreira
    Luis N. Pereira
    Mark Oppe
    Quality of Life Research, 2014, 23 : 413 - 423
  • [34] A US valuation of the EQ-5D
    Fryback, DG
    MEDICAL CARE, 2005, 43 (03) : 199 - 200
  • [35] EUROPEAN UNION 5 (EU5) NORMS FOR THE 3-LEVEL EQ-5D (EQ-5D-3L) QUESTIONNAIRE
    Janssen, B.
    Pickard, A. S.
    Shaw, J. W.
    VALUE IN HEALTH, 2018, 21 : S322 - S323
  • [36] PERFORMANCE OF PROXY-REPORTED EQ-5D YOUTH VERSION 5-LEVEL (EQ-5D-Y-5L) IN COMPARISON WITH THREE-LEVEL (EQ-5D-Y-3L) IN CHINESE PATIENTS WITH ADOLESCENT IDIOPATHIC SCOLIOSIS
    Lin, J.
    Wong, C. K. H.
    Cheung, J. P. Y.
    Cheung, P. W. H.
    Luo, N.
    VALUE IN HEALTH, 2021, 24 : S105 - S105
  • [37] Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
    Ferreira, Lara N.
    Ferreira, Pedro L.
    Ribeiro, Filipa P.
    Pereira, Luis N.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [38] Performance of the EQ-5D in patients with irritable bowel syndrome
    Bushnell, DM
    Martin, ML
    Ricci, JF
    Bracco, A
    VALUE IN HEALTH, 2006, 9 (02) : 90 - 97
  • [39] Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
    Lara N. Ferreira
    Pedro L. Ferreira
    Filipa P. Ribeiro
    Luis N. Pereira
    Health and Quality of Life Outcomes, 14
  • [40] Comparing and assessing the performance of the EQ-5D-3L and the EQ-5D-5L in young adults
    Ferreira, Pedro L.
    Ferreira, Lara N.
    Pereira, Luis N.
    Perdigao, Filipa
    QUALITY OF LIFE RESEARCH, 2014, 23 : 30 - 31